Chandana Mishra, MD
Endocrinology, Diabetes & Metabolism · Scottsdale, AZNPI 1174626667
Payments from drug & device makers
Across 340 payments — averaging $33.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mannkind Corporation$4K
- Amgen$832
- Corcept Therapeutics$738
- Lilly USA, LLC$690
- Abbott$484
- Rhythm Pharmaceuticals, Inc.$409
- plus $4K from 34 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mannkind Corporation | 24 | $4,109 |
| Amgen(2 entities) | 32 | $832 |
| Corcept Therapeutics | 14 | $738 |
| Lilly USA, LLC | 36 | $690 |
| Abbott | 44 | $484 |
| Rhythm Pharmaceuticals, Inc. | 5 | $409 |
| Dexcom, Inc. | 16 | $386 |
| Recordati_rare_diseases_inc. | 4 | $377 |
| Insulet Corporation | 15 | $367 |
| Boehringer Ingelheim | 15 | $353 |
| Novo Nordisk | 24 | $304 |
| BETA Bionics, Inc. | 22 | $291 |
| Sequel Med Tech, LLC | 3 | $279 |
| Sanofi-aventis U.S. LLC | 16 | $233 |
| AbbVie | 9 | $166 |
| Cequr Corporation | 2 | $105 |
| Medtronic(2 entities) | 4 | $104 |
| Chiesi USA, Inc. | 4 | $95 |
| Pfizer | 6 | $92 |
| AstraZeneca(2 entities) | 5 | $85 |
| Xeris Pharmaceuticals, Inc. | 4 | $75 |
| Merck | 5 | $73 |
| Radius Health, Inc. | 3 | $71 |
| Novartis | 3 | $69 |
| Soleno Therapeutics, Inc. | 3 | $65 |
| Lifescan, Inc. | 3 | $64 |
| Tandem Diabetes Care, Inc. | 2 | $48 |
| Verity Pharmaceuticals Inc. | 2 | $46 |
| Amneal Pharmaceuticals LLC | 2 | $36 |
| Johnson & Johnson | 2 | $33 |
| Amarin Pharma, Inc. | 2 | $30 |
| Madrigal Pharmaceuticals | 1 | $29 |
| Neurocrine Biosciences, Inc. | 1 | $28 |
| Ascendis Pharma Endocrinology Inc | 1 | $27 |
| Almatica Pharma LLC | 1 | $25 |
| Antares Pharma, Inc. | 1 | $23 |
| Averitas Pharma Inc. | 1 | $18 |
| Amphastar Pharmaceuticals, Inc. | 1 | $16 |
| Bayer | 1 | $15 |
| Shire North American Group Inc | 1 | $11 |
How this compares
$11,300 in reported general payments places this provider in the 75th percentile of 148 endocrinology, diabetes & metabolism providers in Arizona.
See all endocrinology, diabetes & metabolism providers in Arizona →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Scottsdale
- Amir HarariScottsdale$361K
- Kristina BlohmScottsdale$220K
- Andrea FerencziScottsdale$137K
- Abdul Razzak AlamirScottsdale$34K
- Sreedevi ReddyScottsdale$28K
- Grace Zlaket MattaScottsdale$17K
- Heather SaranScottsdale$14K
- Vincent LiouScottsdale$10K
- Kimberlee BrontsemaScottsdale$9K
- Dena HaddadScottsdale$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.